Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · IEX Real-Time Price · USD
11.21
-0.79 (-6.58%)
At close: May 17, 2024, 4:00 PM
10.82
-0.39 (-3.48%)
After-hours: May 17, 2024, 4:26 PM EDT

Cidara Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013
Revenue
63.9164.4549.5712.0720.9200000
Upgrade
Revenue Growth (YoY)
-0.84%30.01%310.81%-42.30%------
Upgrade
Cost of Revenue
1.52000000000
Upgrade
Gross Profit
62.3864.4549.5712.0720.9200000
Upgrade
Selling, General & Admin
18.3320.5518.7415.916.2414.1412.912.748.843.31
Upgrade
Research & Development
68.5377.4173.0968.0246.449.1442.8235.723.486.71
Upgrade
Other Operating Expenses
0000000001.61
Upgrade
Operating Expenses
86.8797.9591.8383.9262.6463.2955.7248.4432.3111.62
Upgrade
Operating Income
-24.48-33.5-42.26-71.85-41.72-63.29-55.72-48.44-32.31-11.62
Upgrade
Interest Expense / Income
000.210.26-0.22-0.630.010.270.12-0.09
Upgrade
Other Expense / Income
-2-0.19---0.41-3.64--0.54-0.240.36
Upgrade
Pretax Income
-22.49-33.31-42.47-72.11-41.09-59.02-55.73-48.17-32.19-11.89
Upgrade
Income Tax
0.440.2700000000
Upgrade
Net Income
-22.93-33.58-42.47-72.11-41.09-59.02-55.73-48.17-32.19-11.89
Upgrade
Preferred Dividends
0002.76010.330000
Upgrade
Net Income Common
-22.93-33.58-42.47-74.87-41.09-69.35-55.73-48.17-32.19-11.89
Upgrade
Shares Outstanding (Basic)
4332111100
Upgrade
Shares Outstanding (Diluted)
4332111100
Upgrade
Shares Change
25.15%33.18%26.22%38.83%15.71%47.82%20.79%46.05%1110.01%153.29%
Upgrade
EPS (Basic)
-5.20-9.60-16.20-36.00-27.40-53.60-63.60-66.40-65.00-290.20
Upgrade
EPS (Diluted)
-5.20-9.60-16.20-36.00-27.40-53.60-63.60-66.40-65.00-290.20
Upgrade
Free Cash Flow
-22.94-28.59-25.27-54.6-28.57-56.88-50.22-40.17-27.13-8.7
Upgrade
Free Cash Flow Per Share
-5.25-8.19-9.64-26.27-19.09-43.98-57.39-55.45-54.69-212.25
Upgrade
Gross Margin
97.62%100.00%100.00%100.00%100.00%-----
Upgrade
Operating Margin
-38.31%-51.98%-85.24%-595.42%-199.49%-----
Upgrade
Profit Margin
-35.88%-52.11%-85.67%-620.48%-196.47%-----
Upgrade
Free Cash Flow Margin
-35.89%-44.36%-50.98%-452.45%-136.59%-----
Upgrade
EBITDA
-21.21-32.19-42.07-71.56-40.99-59.12-55.05-47.16-31.61-11.8
Upgrade
EBITDA Margin
-33.19%-49.94%-84.86%-593.05%-195.96%-----
Upgrade
Depreciation & Amortization
1.281.120.190.290.330.520.670.730.460.18
Upgrade
EBIT
-22.49-33.31-42.26-71.85-41.31-59.65-55.72-47.89-32.07-11.98
Upgrade
EBIT Margin
-35.19%-51.69%-85.24%-595.42%-197.53%-----
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).